fbpx
RESEARCH

PROLIGHT: Commercial prototype marks an important milestone towards upcoming studies

Analys, Research

The arrival of the first commercial prototype instruments for Prolight’s Psyros Point of Care...

Read More

PROLIGHT: Advancing with strengthened financials towards clinical performance study in 2025

Analys, Research

Prolight continues to make progress with its proprietary Psyros platform, with a pre-validation...

Read More

NANEXA: Progress for rival at Novo illustrates the significant value potential in Nanexa

Analys, Research

NEX-22 is progressing as expected, with the last patient in Phase I treated, results anticipated...

Read More

CRUNCHFISH: Q3 report webinar

Analys, Research

On Friday Nov 1st, 2024 Crunchfish hosted a webinar in connection with the Q3’24 report,...

Read More

TALLINK: All about the Dividend

Okategoriserade, Research

RESEARCH COLLABORATION WITH ENLIGHT RESEARCH  Q3 Sales and Profits beat estimates, but the...

Read More

CRUNCHFISH: Rights issue to stay the course on extended timeline

Analys, Research

As discussed in our previous update, Crunchfish has now settled on a path forward for the...

Read More

GRANGEX: Emerging as Europe’s top DR concentrate developer

Analys, Research

With the dust settling after the acquisition of Sydvaranger and the updated DFS for Dannemora in...

Read More

MOTION DISPLAY: Strong gross margin driving another profitable quarter  

Analys, Research

MODI reported Q2’24 sales largely in line with last year, at SEK 7.4m compared to SEK 7.6m in...

Read More